Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing

TXG

10x Genomics Inc

Last Close
71.22
Oct 26 • 7:48 AM ET Dollar change-0.33 Percentage change(-0.46%)
Overview Compare Short Interest Financials Options Filings Dilution
Healthcare Medical Devices USA Mid NASD
Oct 21, 12:02 PMThermo Fisher and Danaher results lift life-science tools, driving 10x Genomics up 8%
Peers: BRKR BIO ILMN TECH QTRX PACB ALMR LAB A TMO
 | Held by: VTI VB IWM ARKG ARKE ARKK VBK VXF IWO IBB
Scroll to Statements
Index
RUT
Market Cap
9.28B
Enterprise Value
8.81B
Income
-75.12M
Sales
616.91M
Book/sh
6.34
Cash/sh
4.24
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
1178
IPO
Sep 12, 2019
P/E
-
Forward P/E
-
PEG
-
P/S
15.04
P/B
11.24
P/C
16.81
P/FCF
76.41
EV/EBITDA
-
EV/Sales
14.27
Quick Ratio
5.25
Current Ratio
5.69
Debt/Eq
0.10
LT Debt/Eq
0.08
Option/Short
Yes / Yes
EPS (ttm)
-0.59
EPS next Y
-0.72
EPS next Q
-0.27
EPS this Y
-113.17%
EPS next Y
3.46%
EPS next 5Y
-6.91%
EPS past 3/5Y
37.90% 42.10%
Sales past 3/5Y
7.57% 16.55%
EPS Y/Y TTM
15.82%
Sales Y/Y TTM
-4.28%
EPS Q/Q
-149.75%
Sales Q/Q
-12.65%
Earnings
Nov 05 AMC
EPS/Sales Surpr.
42.41% 2.97%
Insider Own
10.85%
Insider Trans
-1.93%
Inst Own
103.56%
Inst Trans
5.83%
ROA
-7.47%
ROE
-9.40%
ROIC
-8.42%
Gross Margin
70.58%
Oper. Margin
-14.12%
Profit Margin
-12.18%
SMA20
-9.09%
SMA50
-1.99%
SMA200
80.73%
Trades
Shs Outstand
120.20M
Shs Float
116.15M
Short Float
13.23%
Short Ratio
4.60
Short Interest
15.37M
52W High
102.81 -30.73%
52W Low
12.34 477.15%
Volatility
8.78% 9.13%
ATR (14)
6.04
RSI (14)
45.57
Beta
2.02
Rel Volume
0.01
Avg Volume
3.34M
Volume
1,344
Perf Week
1.90%
Perf Month
-16.91%
Perf Quarter
51.37%
Perf Half Y
219.66%
Perf YTD
336.66%
Perf Year
417.21%
Perf 3Y
90.99%
Perf 5Y
-57.00%
Perf 10Y
-
Recom
2.41
Target Price
77.50
Prev Close
71.55
Price
71.22
Change %
-0.46%
Show Previous Ratings
Show Previous News
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SULIMAN SHEHNAAZDirectorSep 22 '26Sale81.195,723464,66823,792Sep 24 04:30 PM
Saxonov SergeChief Executive OfficerSep 22 '26Sale81.2225,0002,030,5621,050,249Sep 24 04:29 PM
Shehnaaz SulimanAffiliateSep 22 '26Proposed Sale79.105,723452,689Sep 22 06:27 PM
Taich AdamChief Financial OfficerSep 09 '26Sale64.5746,3882,995,470316,344Sep 11 04:47 PM
ADAM TAICHOfficerSep 09 '26Proposed Sale64.5746,3882,995,470Sep 09 04:28 PM
STUELPNAGEL JOHN RDirectorSep 03 '26Sale61.7520,0001,235,072328,436Sep 08 07:00 PM
STUELPNAGEL JOHN RDirectorSep 03 '26Proposed Sale61.7520,0001,235,046Sep 03 02:28 PM
Saxonov SergeChief Executive OfficerAug 26 '26Sale63.6910,486667,9011,075,349Aug 28 07:22 PM
Serge SaxonovDirector, CEOAug 26 '26Proposed Sale62.1835,4862,206,654Aug 26 06:09 PM
Saxonov SergeChief Executive OfficerAug 24 '26Sale63.0218,5451,168,7751,085,835Aug 26 04:46 PM
Taich AdamChief Financial OfficerAug 24 '26Sale63.0217,1661,081,853362,732Aug 26 04:44 PM
Hindson Benjamin J.See RemarksAug 24 '26Sale63.0213,818870,860488,182Aug 26 04:43 PM
SULIMAN SHEHNAAZDirectorAug 24 '26Sale63.652,207140,47829,515Aug 26 04:42 PM
Taich AdamOfficerAug 24 '26Proposed Sale65.1216,6141,081,904Aug 24 06:53 PM
Saxonov SergeOfficerAug 24 '26Proposed Sale65.1217,9481,168,774Aug 24 06:24 PM
Hindson Benjamin J.OfficerAug 24 '26Proposed Sale65.1213,373870,850Aug 24 06:05 PM
Shehnaaz SulimanAffiliateAug 24 '26Proposed Sale65.122,207143,720Aug 24 05:27 PM
Teichmann Sarah A.DirectorAug 13 '26Sale57.295,278302,37730,331Aug 17 04:08 PM
Teichmann Sarah A.DirectorAug 14 '26Sale57.152,273129,90228,058Aug 17 04:08 PM
SARAH A POLONIUS-TEICHMANNDirectorAug 14 '26Proposed Sale57.152,273129,902Aug 14 04:35 PM
SARAH A POLONIUS-TEICHMANNDirectorAug 13 '26Proposed Sale57.295,278302,377Aug 13 04:16 PM
STUELPNAGEL JOHN RDirectorAug 11 '26Sale57.7520,0001,155,055348,436Aug 13 04:11 PM
STUELPNAGEL JOHN RDirectorAug 11 '26Proposed Sale57.7520,0001,155,032Aug 11 12:04 PM
Saxonov SergeChief Executive OfficerJun 22 '26Sale34.4430,0001,033,2691,108,380Jun 24 04:22 PM
SULIMAN SHEHNAAZDirectorJun 16 '26Sale32.635,723186,75631,722Jun 18 04:08 PM
Shehnaaz SulimanAffiliateJun 16 '26Proposed Sale32.225,723184,395Jun 16 07:58 PM
Saxonov SergeChief Executive OfficerMay 22 '26Sale24.4418,175444,2241,149,098May 27 05:57 PM
Saxonov SergeChief Executive OfficerMay 26 '26Sale24.7110,718264,8331,138,380May 27 05:57 PM
Hindson Benjamin J.See RemarksMay 22 '26Sale24.4411,595283,399502,000May 27 05:56 PM
Taich AdamChief Financial OfficerMay 22 '26Sale24.4415,098369,018379,898May 27 05:55 PM
Serge SaxonovDirector, CEOMay 26 '26Proposed Sale23.6840,718964,202May 26 04:56 PM
Saxonov SergeOfficerMay 22 '26Proposed Sale24.6817,948442,957May 22 08:31 PM
Hindson Benjamin J.OfficerMay 22 '26Proposed Sale24.689,430232,732May 22 06:26 PM
Taich AdamOfficerMay 22 '26Proposed Sale24.6811,779290,706May 22 05:40 PM
Saxonov SergeChief Executive OfficerApr 14 '26Sale24.565,000122,7841,167,273Apr 16 04:07 PM
Saxonov SergeChief Executive OfficerMar 23 '26Sale19.1310,000191,2971,177,273Mar 25 05:15 PM
Saxonov SergeChief Executive OfficerMar 24 '26Sale19.525,00097,6121,172,273Mar 25 05:15 PM
Saxonov SergeChief Executive OfficerMar 02 '26Sale22.7316,152367,0971,203,667Mar 04 04:14 PM
Serge SaxonovDirector, CEOMar 02 '26Proposed Sale22.1341,152910,694Mar 02 04:21 PM
Teichmann Sarah A.DirectorFeb 25 '26Sale19.417,579147,10826,780Feb 27 04:01 PM
Saxonov SergeChief Executive OfficerFeb 23 '26Sale18.589,632178,9281,061,924Feb 25 04:52 PM
Taich AdamChief Financial OfficerFeb 23 '26Sale18.588,968166,593288,417Feb 25 04:51 PM
Hindson Benjamin J.See RemarksFeb 23 '26Sale18.587,826145,379424,779Feb 25 04:51 PM
SARAH A POLONIUS-TEICHMANNDirectorFeb 25 '26Proposed Sale19.417,579147,108Feb 25 04:44 PM
Hindson Benjamin J.OfficerFeb 23 '26Proposed Sale19.198,301159,269Feb 23 05:30 PM
Saxonov SergeOfficerFeb 23 '26Proposed Sale19.1910,129194,376Feb 23 05:15 PM
Taich AdamOfficerFeb 23 '26Proposed Sale19.199,188176,318Feb 23 05:00 PM
Saxonov SergeChief Executive OfficerJan 05 '26Option Exercise1.2050,00060,0001,071,556Jan 07 04:52 PM
Taich AdamChief Financial OfficerNov 24 '25Sale19.0011,888225,852297,385Nov 25 05:24 PM
Hindson Benjamin J.See RemarksNov 24 '25Sale19.008,283157,363432,605Nov 25 05:24 PM
Saxonov SergeChief Executive OfficerNov 24 '25Sale19.0013,261251,9361,021,556Nov 25 05:23 PM
Hindson Benjamin J.OfficerNov 24 '25Proposed Sale18.347,392135,569Nov 24 05:32 PM
Saxonov SergeOfficerNov 24 '25Proposed Sale18.3413,096240,181Nov 24 04:56 PM
Taich AdamOfficerNov 24 '25Proposed Sale18.3411,312207,462Nov 24 04:28 PM
10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company's products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.
Co-FounderDr. Serge Saxonov Ph.D.
Co-FounderDr. Benjamin J. Hindson Ph.D.
CFOMr. Adam S. Taich
Chief of Global OperationsMr. Jim Goodrich
Founding Scientist & CTOMr. Michael Schnall-Levin Ph.D.
open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)